drospirenone has been researched along with Polycystic Ovarian Syndrome in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (35.90) | 29.6817 |
| 2010's | 24 (61.54) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Luisi, S; Meczekalski, B; Petraglia, F; Podfigurna, A | 1 |
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Cheng, HY; Ko, KT; Tzang, RF | 1 |
| Abbas, AM; Abdel-Maboud, M; Abdelghany, MF; Bahbah, EI; El-Din, AA; Elgebaly, A; Gadelkarim, M; Ismail, A; Menshawy, A; Samy, A | 1 |
| Aksoy, DY; Arusoglu, G; Cinar, N; Koksal, G; Tapan, S; Yildiz, BO | 1 |
| Bajuk Studen, K; Jensterle Sever, M; Pfeifer, M | 1 |
| Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
| Busacca, M; De Cicco, S; Gagliano, D; Guido, M; Lanzone, A; Romualdi, D | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
| Aksoy, DY; Arusoglu, G; Aydin, K; Cinar, N; Koksal, G; Yildiz, BO | 1 |
| Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
| Bhattacharya, SM; DasMukhopadhyay, L; Jha, A | 1 |
| Feng, GM; Huang, W; Song, Y; Wang, QS; Wang, QY; Xiao, L | 1 |
| Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D | 1 |
| Li, J; Ren, J; Sun, W | 1 |
| Ozdemir, M; Ozdemir, S; Toy, H | 1 |
| Gezginç, K; Görkemli, H; Kiyici, A; Ozdemir, M; Ozdemir, S | 1 |
| Noyan, V; Orbak, Z; Sağsöz, N; Uçar, B; Yildiz, L; Yücel, A | 1 |
| Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D | 1 |
| Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
| Bayraktar, M; Cinar, N; Harmanci, A; Yildiz, BO | 1 |
| Haydardedeoglu, B; Kilicdag, EB; Parlakgumus, AH; Zeyneloglu, HB | 1 |
| Bhattacharya, SM; Jha, A | 1 |
| Dokras, A | 1 |
| Aksoy, DY; Aydin, K; Bozdag, G; Cinar, N; Yildiz, BO | 1 |
| de Zegher, F; Ibáñez, L | 2 |
| Apa, R; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Selvaggi, L; Suriano, R | 1 |
| Balen, A; Barth, J; Mook, K; Palep-Singh, M | 1 |
| Cabré, S; De Zegher, F; Ibáñez, L; Valls, C | 1 |
| Bhathena, RK | 1 |
| Amaliev, I; Ivancheva, Kh; Mitkov, M; Pekhlivanov, B | 1 |
| Centeno, I; David, M; Gutierrez, E; Kahi, D; Pérez, M; Sánchez, LA | 1 |
| Cianci, A; De Leo, V; Morgante, G; Musacchio, MC; Petraglia, F; Piomboni, P | 1 |
| Mitkov, M; Pehlivanov, B | 1 |
| Bakalianou, K; Creatsas, G; Gregoriou, O; Konidaris, S; Papadias, K; Salakos, N; Vrachnis, N | 1 |
3 review(s) available for drospirenone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.
Topics: Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Humans; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone | 2019 |
Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenes; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Coronary Artery Disease; Female; Humans; Hypertension; Incretins; Insulin Resistance; Life Style; Metformin; Middle Aged; Obesity; Polycystic Ovary Syndrome; Postmenopause; Renin-Angiotensin System; Risk Factors; Sleep Apnea, Obstructive; Thiazolidinediones; Vascular Stiffness; Weight Reduction Programs | 2013 |
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome | 2017 |
21 trial(s) available for drospirenone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Ethinyl Estradiol; Female; Glucose Clamp Technique; Hirsutism; Humans; Hyperandrogenism; Pilot Projects; Polycystic Ovary Syndrome; Triglycerides | 2013 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; India; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Young Adult | 2016 |
Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
Topics: Adolescent; Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Insulin Resistance; Life Style; Lipids; Metformin; Polycystic Ovary Syndrome; Prospective Studies | 2016 |
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2016 |
Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Androstenes; Carbohydrate Metabolism; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lipid Metabolism; Luteinizing Hormone; Medroxyprogesterone Acetate; Menstrual Cycle; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2008 |
The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
Topics: Adult; Androstenes; Contraceptives, Oral; Dose-Response Relationship, Drug; Estrogens; Female; Ghrelin; Humans; Leptin; Polycystic Ovary Syndrome; Treatment Outcome | 2009 |
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2010 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
Topics: Adult; Androstenes; Clinical Protocols; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic; Young Adult | 2012 |
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Blood Glucose; Blood Pressure; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Female; Follow-Up Studies; Hirsutism; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2012 |
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins | 2004 |
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.
Topics: Adult; Androstenes; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Pilot Projects; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors | 2005 |
Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
Topics: Adult; Androstenes; Blood Glucose; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Severity of Illness Index; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2007 |
Treatment of hirsutism with combined pill containing drospirenone.
Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Greece; Hirsutism; Humans; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2008 |
15 other study(ies) available for drospirenone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone).
Topics: Adult; Androstenes; Blood Glucose; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2020 |
Metformin-induced first-episode psychosis in patient with polycystic ovary syndrome using drospirenone.
Topics: Adult; Androstenes; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Psychoses, Substance-Induced; Young Adult | 2019 |
Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
Topics: Adolescent; Adult; Androstenes; Basal Metabolism; Body Weight; Cholecystokinin; Contraceptives, Oral; Eating; Estrogens; Ethinyl Estradiol; Female; Ghrelin; Humans; Mineralocorticoid Receptor Antagonists; Peptide YY; Polycystic Ovary Syndrome; Prospective Studies; Satiety Response; Young Adult | 2013 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.
Topics: Adult; Androstenes; Area Under Curve; Blood Glucose; Estradiol; Fasting; Female; Glucagon-Like Peptide 1; Humans; Insulin; Polycystic Ovary Syndrome; Postprandial Period; Prospective Studies; Young Adult | 2014 |
Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
Topics: Adult; Androstenes; Ethinyl Estradiol; Female; Humans; Papilloma; Polycystic Ovary Syndrome | 2009 |
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome | 2010 |
Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.
Topics: Androstenes; Ethinyl Estradiol; Female; Humans; Male; Metformin; Middle Aged; Polycystic Ovary Syndrome; Thinness | 2013 |
In search of the best combined oral contraceptive for treatment of polycystic ovary syndrome.
Topics: Androstenes; Cyproterone Acetate; Desogestrel; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 2012 |
Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
Topics: Adolescent; Adult; Androstenes; Body Composition; Case-Control Studies; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Thinness; Young Adult | 2013 |
An observational study of Yasmin in the management of women with polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androstenes; Contraceptive Agents; Drug Combinations; Female; Hospitals, Teaching; Humans; Mineralocorticoid Receptor Antagonists; Observation; Pilot Projects; Polycystic Ovary Syndrome | 2004 |
Drospirenone and PCOS.
Topics: Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome | 2005 |
[Use of yasmin in the treatment of women with polycystic ovary syndrome].
Topics: Adult; Androstenes; Body Mass Index; Drug Administration Schedule; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome; Waist-Hip Ratio | 2006 |
Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
Topics: Adult; Androgens; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Time Factors | 2007 |
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies | 2007 |